• V.M. Nedoborenko Higher State Educational Establishment of Ukraine "Ukrainian Medical Stomatological Academy"
  • I.P. Kaidashev Higher State Educational Establishment of Ukraine "Ukrainian Medical Stomatological Academy"
Keywords: obesity, low-grade systemic inflammation, hepcidin, iron deficiency anemia


Iron deficiency anemia and obesity have become a global problem affecting not only high income countries but also developing countries. Experimental and clinical studies indicate that there is a relationship between iron metabolism and weight status. Obesity is associated with low-grade systemic inflammation and elevated hepcidin concentrations. Hepcidin is the key regulator of systemic iron homeostasis. This review summarizes the current understanding of the dysregulation of iron homeostasis in obesity and leads assumptions about treatment.


Download data is not yet available.


1. Kassebaum NJ, Jasrasaria R, Naghavi M, et al. A systematic analysis of global anemia burden from 1990 to 2010. Blood 2014;123:615-24.
2. Kopelman PG. Obesity as a medical problem. Nature (2000) 404:635–43.
4. Dao MC, Meydani SN (2013) Iron biology, immunology, aging, and obesity: four fields connected by the small peptide hormone hepcidin. Adv Nutr 4:602–617
5. Bertinato J, Aroche C, Plouffe LJ, Lee M, Murtaza Z, Kenney L, Lavergne C, Aziz A. Diet-induced obese rats have higher iron requirements and are more vulnerable to iron deficiency. Eur J Nutr., 2013. 6.
6. Dvoretsky L.I., Ivleva L.I., Obesity and iron deficiency. One more comorbidity? Archive of internal medicine. 2015; (5):9-16. (In Russ.)
7. Ganz T. Hepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation. Blood 2003; 102(3):783–8.
8. Cildir G, Akincilar SC & Tergaonkar V 2013 Chronic adipose tissue inflammation: all immune cells on the stage. Trends in Molecular Medicine 19 487–500.
9. Mraz M, Haluzik M (2014) The role of adipose tissue immune cells in obesity and low-grade inflammation. J Endocrinol 222: R113-127
10. Herder C., Schneitler S., Rathmann W. et al.(2007) Low-grade inflammation, obesity, and insulin resistance in adolescents. J. Clin. Endocrinol. Metab., 92(12): 4569–4574.
11. Rasin M.S., Kajdashev I.P. (2014) The role of nuclear transcription factors in modern syntropy internal pathology (review). Ukrainian Medical Journal., № 1 (99) – I/II: 17-21
12. Medzhitov R 2008 Origin and physiological roles of inflammation. Nature 454 428–435.
13. Lee, B.-C., & Lee, J. (2014). Cellular and Molecular Players in Adipose Tissue Inflammation in the Development of Obesity-induced Insulin Resistance. Biochimica et Biophysica Acta, 1842(3), 446–462.
14. Zeyda M, Stulnig TM. Obesity, inflammation and insulin resistance-a mini-review. Gerontology 2009; 55:379-386.
15. J. Lee. Adipose tissue macrophages in the development of obesity-induced inflammation, insulin resistance and Type 2 Diabetes Arch. Pharmacal Res., 36 (2013), pp. 208–222
16. Poli M, Asperti M, Ruzzenenti P, Regoni M, Arosio P (2014) Hepcidin antagonists for potential treatments of disorders with hepcidin excess. Front Pharmacol 5(86):1–13
17. Nemeth E, Tuttle MS, Powelson J, Vaughn MB, Donovan A, Ward DM, Ganz T, Kaplan J. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science. 2004;306:2090–3
18. Nairz M, Haschka D, Demetz E, et al Iron at the interface of immunity and infection. Front Pharmacol 2014;5:152
19. Collins JF, Wessling-Resnick M, Knutson MD. Hepcidin regulation of iron transport. J Nutr. 2008 Nov;138(11):2284-8.
20. Bekri S., Gual P., Anty R., Luciani N., Dahman M., Ramesh B.,Iannelli A., Staccini-Myx A., Casanova D., Ben Amor I. et al.(2006) Increased adipose tissue expression of hepcidin insevere obesity is independent from diabetes and NASH. Gastroenterology 131: 788-796.
21. Nikonorov А.А., Tinkov A.A., Popova E.V., Nemereshina O.N., Gatiatulina E.R., Skalnaya M.G., Skalny A.V. (2015) Iron in obesity: a victim or suspect. Trece elements in medicine (Moscow)., 16(2): 3-9
22. Tussing-Humphreys L, Pusatcioglu C, Nemeth E, Braunschweig C. Rethinking iron regulation and assessment in iron deficiency, anemia of chronic disease, and obesity: introducing hepcidin. J Acad Nutr Diet. 2012;112:391-400
How to Cite
Nedoborenko, V., & Kaidashev, I. (2017). THE PATHOGENESIS OF IRON DEFICIENCY ANEMIA IN OBESITY. The Medical and Ecological Problems, 20(3-4), 13-15. Retrieved from